Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014

Pages: 79 Published: November 01, 2014 Report Code: GDHC2425CTIDB

GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

– Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

– Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy

– Understand the dynamics of a particular indication in a condensed manner

– Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

– Obtain discontinued trial listing for trials across the globe

– Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 6

Cryptococcal Meningitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Cryptococcal Meningitis 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Pfizer Inc. 30

Clinical Trial Overview of Pfizer Inc. 30

TTY Biopharm Company Limited 31

Clinical Trial Overview of TTY Biopharm Company Limited 31

Novartis AG 32

Clinical Trial Overview of Novartis AG 32

Liposome Company, Inc 33

Clinical Trial Overview of Liposome Company, Inc 33

Alkermes Plc 34

Clinical Trial Overview of Alkermes Plc 34

Clinical Trial Overview of Top Institutes / Government 35

The National Institute of Allergy and Infectious Diseases 35

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35

St. George's University of London 36

Clinical Trial Overview of St. George's University of London 36

University of Minnesota 37

Clinical Trial Overview of University of Minnesota 37

University of Oxford 38

Clinical Trial Overview of University of Oxford 38

University of Zimbabwe-Parirenyatwa Clinical Research Center 39

Clinical Trial Overview of University of Zimbabwe-Parirenyatwa Clinical Research Center 39

Department of Biotechnology, India 40

Clinical Trial Overview of Department of Biotechnology, India 40

French National Agency for Research on AIDS and Viral Hepatitis 41

Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 41

Five Key Clinical Profiles 42

Appendix 76

Abbreviations 76

Definitions 76

Research Methodology 77

Secondary Research 77

About GlobalData 78

Contact Us 78

Disclaimer 78

Source 79

List of Tables

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region, 2014* 7

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Cryptococcal Meningitis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11

Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13

Cryptococcal Meningitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15

Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18

Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014* 20

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23

Cryptococcal Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014* 24

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25

Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by TTY Biopharm Company Limited, 2014* 31

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Liposome Company, Inc, 2014* 33

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Plc, 2014* 34

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. George's University of London, 2014* 36

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 37

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 38

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zimbabwe-Parirenyatwa Clinical Research Center, 2014* 39

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Biotechnology, India, 2014* 40

Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 41

List of Figures

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10

Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12

Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13

Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15

Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18

Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21

Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25

Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28

Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29

GlobalData Methodology 77

$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.